AXNX

Axonics (AXNX)

Axonics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:AXNX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/01	05:01	Business Wire	Axonics Reports First Quarter 2024 Financial Results	NASDAQ:AXNX	Axonics Inc
2024/04/24	19:30	PR Newswire (US)	Boston Scientific Announces Results for First Quarter 2024	NASDAQ:AXNX	Axonics Inc
2024/03/23	05:01	Business Wire	Axonics Stockholders Approve Merger Agreement with Boston Scientific	NASDAQ:AXNX	Axonics Inc
2024/03/22	05:54	Business Wire	Axonics Provides Update on Inter Partes Review Proceedings	NASDAQ:AXNX	Axonics Inc
2024/03/14	19:00	Business Wire	Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System	NASDAQ:AXNX	Axonics Inc
2024/03/08	07:24	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:AXNX	Axonics Inc
2024/03/01	06:01	Business Wire	Axonics Responds to ITC Action by Medtronic	NASDAQ:AXNX	Axonics Inc
2024/02/29	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AXNX	Axonics Inc
2024/02/29	06:01	Business Wire	Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results	NASDAQ:AXNX	Axonics Inc
2024/02/22	22:00	Edgar (US Regulatory)	Form DEFM14A - Definitive proxy statement relating to merger or acquisition	NASDAQ:AXNX	Axonics Inc
2024/02/03	08:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AXNX	Axonics Inc
2024/02/03	07:59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AXNX	Axonics Inc
2024/02/03	07:59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AXNX	Axonics Inc
2024/02/03	07:59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AXNX	Axonics Inc
2024/01/31	20:30	PR Newswire (US)	Boston Scientific Announces Results for Fourth Quarter and Full Year 2023	NASDAQ:AXNX	Axonics Inc
2024/01/11	10:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AXNX	Axonics Inc
2024/01/11	05:07	PR Newswire (US)	Kuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to Contact Law Firm	NASDAQ:AXNX	Axonics Inc
2024/01/09	07:19	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:AXNX	Axonics Inc
2024/01/09	07:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AXNX	Axonics Inc
2024/01/09	06:55	PR Newswire (US)	ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc.	NASDAQ:AXNX	Axonics Inc
2024/01/09	01:36	Dow Jones News	Axonics Shares Climb 20% After Acquisition by Boston Scientific	NASDAQ:AXNX	Axonics Inc
2024/01/08	22:47	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AXNX	Axonics Inc
2024/01/08	21:41	Dow Jones News	Boston Scientific To Acquire Axonics For About $3.7 Billion	NASDAQ:AXNX	Axonics Inc
2024/01/08	21:00	PR Newswire (US)	Boston Scientific Announces Agreement to Acquire Axonics, Inc.	NASDAQ:AXNX	Axonics Inc
2024/01/08	21:00	Business Wire	Axonics Announces Definitive Agreement to be Acquired by Boston Scientific	NASDAQ:AXNX	Axonics Inc
2024/01/08	21:00	Business Wire	Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue	NASDAQ:AXNX	Axonics Inc
2023/12/29	09:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AXNX	Axonics Inc
2023/12/28	06:01	Business Wire	Axonics to Present at the J.P. Morgan Healthcare Conference	NASDAQ:AXNX	Axonics Inc
2023/12/27	03:31	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AXNX	Axonics Inc
2023/11/07	02:00	GlobeNewswire Inc.	Revolutionizing Care: NeuroQure’s Groundbreaking Path to Treating Genetic Intellectual Disabilities	NASDAQ:AXNX	Axonics Inc